Anthera Pharmaceuticals Inc·4

Jun 13, 7:33 PM ET

Anthera Pharmaceuticals Inc 4

4 · Anthera Pharmaceuticals Inc · Filed Jun 13, 2016

Insider Transaction Report

Form 4
Period: 2016-06-09
THOMPSON JOHN CRAIG
DirectorPresident & CEO
Transactions
  • Award

    Stock option (right to buy)

    2016-06-09+170,000170,000 total
    Exercise: $3.52Exp: 2026-06-09Common Stock (170,000 underlying)
Footnotes (1)
  • [F1]The option shall vest and become exercisable, if at all, in installments upon the achievement of certain performance milestones as approved by the Company's Board of Directors.

Documents

1 file
  • 4
    marketforms-35721.xmlPrimary

    PRIMARY DOCUMENT